KakOli, Thats a good years worth of news. China announcememt must be very close.
French trials 200 pax will be a biggie if it goes Avita's way, that trial is looking at RECELL from an economic treatment angle to establish if SPray on Skin should be the standard of care in France with medicare support.
This trial will provide the data needed for rebates in other countries.
